1 year return (CAGR)
23237.28%
Aktis Oncology, Inc. Common stock Exchange (NASDAQ, USD)
AKTS
19.72
-2.39 (-10.81%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
65.25%
5 year return (CAGR)
19.45%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.06B
Price/Sales
124.97
Ent value
1.05B
Price/Book
2.19
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 21.87 |
| Daily high | 21.87 |
| Daily low | 19.67 |
| Daily Volume | 589K |
| All-time high | 32.23 |
| 1y analyst estimate | 34.81 |
| Beta | - |
| EPS (TTM) | -1.04 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AKTS | S&P500 | |
| Current price drop from All-time high | -38.81% | -1.29% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 18 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -54.22% | -10.68% |
| Avg time to new high | 64 days | 12 days |
| Max time to new high | 974 days | 1805 days |
News
